Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Letters

Cisapride and the Vanessa Young inquest

Wendy Arnott
CMAJ August 21, 2001 165 (4) 395-395-a;
Wendy Arnott
Vice-President Regulatory and Medical Affairs Janssen-Ortho, Inc. Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

A recent CMAJ editorial is misinformed in its statement that Vanessa Young's death was “undoubtedly caused by the drug cisapride.”1 We acknowledge CMAJ's right to express an opinion about this matter, but readers should be given accurate, factual information, including the following.

On April 24, 2001, a coroner's jury concluded that Vanessa Young's arrhythmia and cardiac arrest resulted “from the effects of bulimia nervosa in conjunction with cisapride toxicity and possibly an unknown cofactor such as congenital cardiac defect.” Significant evidence presented at the inquest from a variety of health care professionals indicated that it was highly probable that Vanessa Young had risk factors for cardiac rhythm problems that could have caused her death independently of any medication she may have been taking.

Distribution of cisapride was stopped in Canada on May 29, 2000, whereas in the United States it was stopped on July 14 and inventory remained in pharmacies until mid- August. Pharmacies stopped selling the drug in Canada on August 2.

Cisapride was clearly contraindicated for people at risk of electrolyte imbalances, including those with bulimia, and this information had been included in the prescribing information for the drug for a number of years before it was prescribed to Vanessa Young. As early as 1995, Janssen-Ortho, Inc., began to send letters to physicians and pharmacists in Canada describing the occurrence of serious cardiac rhythm disturbances in certain patients who had taken the drug and highlighting changes to the prescribing information. This new information was also made available to physicians and pharmacists in the Compendium of Pharmaceuticals and Specialties. Physicians and pharmacists rely on prescribing information approved by Health Canada (which is published and updated in the Compendium of Pharmaceuticals and Specialties annually, among other places), not on patient leaflets, to safely and appropriately prescribe and dispense pharmaceutical products.

Consistent with our commitment to patient safety, we will continue to work closely with Health Canada and medical professionals to examine ways to optimize communication of new clinical findings and prescribing information.

Reference

  1. 1.↵
    Lessons from cisapride [editorial]. CMAJ 2001; 164(9):1269.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

CMAJ
Vol. 165, Issue 4
21 Aug 2001
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cisapride and the Vanessa Young inquest
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cisapride and the Vanessa Young inquest
Wendy Arnott
CMAJ Aug 2001, 165 (4) 395-395-a;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Cisapride and the Vanessa Young inquest
Wendy Arnott
CMAJ Aug 2001, 165 (4) 395-395-a;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Reference
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The 5 Ps need an update: toward a comprehensive sexual history
  • Don’t ignore perimenopause
  • Hospital-at-home programs in Canada: challenges and pitfalls
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire